The Distribution and Spectrum of Thalassemia Variants in GUIYANG Region, Southern China

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Date 2025 Feb 7

PMID 39920831

Authors

Xuanyin Zhao

Zhiyu You

Yunyan Deng

Yi Zhou

Dongyang Deng

Jian Quan

Fang Chen

Zhimei Yan

Ya Qi

Leilei Chen

Fang Xiang

Weixian Zheng

Ruyi Zhang

Affiliations

Soon will be listed here.

Abstract

Thalassemia is one of southern China's most common inherited disorders. This retrospective study analyzed the results of thalassemia gene testing conducted on 20,478 individuals from January 1, 2019, to April 31, 2024 in the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine. The cohort consisted of 19,733 females and 745 males, with 1401 individuals testing positive for thalassemia. Among the positive cases, 942 had α thalassemia, 431 had β thalassemia, and 25 had variants in both α and β thalassemia genes. Interestingly, a subgroup of individuals with thalassemia variants not previously documented in medical literature was identified. The study highlighted the prevalence of thalassemia among different ethnic groups, with individuals of Han ethnicity being the most affected. Geographical analysis revealed a concentration of cases in Guizhou Province, particularly in Guiyang city, Bijie, and Qiannan Prefecture. These findings provide valuable insights into the epidemiology of thalassemia in the region and the distribution of affected individuals.

References

Afzal M, Naeem M, Ahmed S, Amin N, Rahim A, Munawar M . Noninvasive prenatal testing of beta-thalassemia for common Pakistani mutations: a comparative study using cell-free fetal DNA from maternal plasma and chorionic villus sampling. Hematology. 2022; 27(1):353-359. DOI: 10.1080/16078454.2022.2045052. View

Huang S, Xu Y, Liu X, Zhou M, Li G, An B . The Prevalence and Spectrum of α-Thalassemia in Guizhou Province of South China. Hemoglobin. 2015; 39(4):260-3. DOI: 10.3109/03630269.2015.1041037. View

Zhang R, Deng D, Ren M, He J, Chen F, Yan S . A color-based FHGC approach facilities DNA-based clinical molecular diagnostics. Genes Dis. 2023; 10(4):1197-1199. PMC: 10311011. DOI: 10.1016/j.gendis.2022.07.007. View

Langer A, Esrick E . β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. Hematology Am Soc Hematol Educ Program. 2021; 2021(1):600-606. PMC: 8791140. DOI: 10.1182/hematology.2021000313. View

Hodroj M, Taher A . Thalassemia and malignancies: Updates from the literature. Ann N Y Acad Sci. 2023; 1529(1):14-20. DOI: 10.1111/nyas.15061. View

Petersen L, Martin I, Moschetti W, Kershaw C, Tsongalis G . Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing. J Clin Microbiol. 2019; 58(1). PMC: 6935936. DOI: 10.1128/JCM.01315-19. View

Zhong K, Shi H, Wu W, Xu H, Wang H, Zhao Z . Genotypic spectrum of α-thalassemia and β-thalassemia in newborns of the Li minority in Hainan province, China. Front Pediatr. 2023; 11:1139387. PMC: 10067758. DOI: 10.3389/fped.2023.1139387. View

Tan M, Bai Y, Zhang X, Sun J, Huang C, Tian R . Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China. Clin Genet. 2021; 99(5):704-712. DOI: 10.1111/cge.13923. View

Lal A, Bansal D . Thalassemia: Common Clinical Queries in Management. Indian J Pediatr. 2019; 87(1):75-81. DOI: 10.1007/s12098-019-03065-5. View

10.

Zhao N, Cao J, Xu J, Liu B, Liu B, Chen D . Targeting RNA with Next- and Third-Generation Sequencing Improves Pathogen Identification in Clinical Samples. Adv Sci (Weinh). 2021; 8(23):e2102593. PMC: 8655164. DOI: 10.1002/advs.202102593. View

11.

Simoneau J, Shah Y . Ironing out β-thalassemia during pregnancy. Blood. 2023; 142(2):128-129. PMC: 10352599. DOI: 10.1182/blood.2023020924. View

12.

Wang W, Hu F, Zhou D, Gale R, Lai Y, Yao H . Thalassaemia in China. Blood Rev. 2023; 60:101074. DOI: 10.1016/j.blre.2023.101074. View

13.

Ruengdit C, Punyamung M, Khamphikham P, Pongpunyayuen P, Intasai N, Pornprasert S . Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia. Hemoglobin. 2022; 45(5):309-313. DOI: 10.1080/03630269.2022.2028634. View

14.

Merkeley H, Bolster L . Thalassemia. CMAJ. 2020; 192(41):E1210. PMC: 7588257. DOI: 10.1503/cmaj.191613. View

15.

Kattamis A, Kwiatkowski J, Aydinok Y . Thalassaemia. Lancet. 2022; 399(10343):2310-2324. DOI: 10.1016/S0140-6736(22)00536-0. View

16.

Almahmoud R, Hussein A, Khaja F, Soliman A, Dewedar H, Al Shareef Z . Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre. BMC Pediatr. 2024; 24(1):244. PMC: 10996095. DOI: 10.1186/s12887-024-04670-w. View

17.

Tarim H, Oz F . Thalassemia Major and Associated Psychosocial Problems: A Narrative Review. Iran J Public Health. 2022; 51(1):12-18. PMC: 8837879. DOI: 10.18502/ijph.v51i1.8287. View

18.

Xian J, Wang Y, He J, Li S, He W, Ma X . Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China. Clin Appl Thromb Hemost. 2022; 28:10760296221119807. PMC: 9393661. DOI: 10.1177/10760296221119807. View

19.

Baird D, Batten S, Sparks S . Alpha- and Beta-thalassemia: Rapid Evidence Review. Am Fam Physician. 2022; 105(3):272-280. View

20.

Alwi Z, Syed-Hassan S . Thalassemia in Malaysia. Hemoglobin. 2022; 46(1):45-52. DOI: 10.1080/03630269.2022.2057326. View